Cargando…
Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin
Metadherin (MTDH), also known as astrocyte-elevated gene-1, was first cloned in 2002 and has been confirmed as an oncogene in numerous types of cancer by previous studies. Overexpression of MTDH has been observed in multiple types of cancer, including breast, esophageal, prostate, cervical and non-s...
Autores principales: | WEI, YONG-BAO, GUO, QIONG, GAO, YUN-LIANG, YAN, BIN, WANG, ZHAO, YANG, JIN-RUI, LIU, WEI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438956/ https://www.ncbi.nlm.nih.gov/pubmed/25684730 http://dx.doi.org/10.3892/mmr.2015.3357 |
Ejemplares similares
-
Metadherin regulates epithelial–mesenchymal transition in carcinoma
por: Wang, Zhao, et al.
Publicado: (2016) -
Metadherin enhances vulnerability of cancer cells to ferroptosis
por: Bi, Jianling, et al.
Publicado: (2019) -
Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression
por: Lai, Trang Huyen, et al.
Publicado: (2021) -
Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin
por: Song, Zhenchuan, et al.
Publicado: (2015) -
MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression
por: Hu, Changmei, et al.
Publicado: (2017)